JXI: Cuff, Nerve

Product code JXI, “Cuff, Nerve” in FDA's classification database, is a Class II device type under 21 CFR 882.5275 (nerve cuff), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 40 clearances under JXI, 29 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
JXI
Regulation
21 CFR 882.5275
Class
II
Panel
Neurology
Clearances
40
Most recent
Apr 9, 2026
Median review, last 2 years
99 days
Third-party review
Not eligible
Implant
Yes

What it covers

A nerve cuff is a tubular silicone rubber sheath used to encase a nerve for aid in repairing the nerve (e.g., to prevent ingrowth of scar tissue) and for capping the end of the nerve to prevent the formation of neuroma (tumors).

The identification in 21 CFR 882.5275, nerve cuff. FDA gives JXI no definition of its own, so the regulation’s describes it.

FDA flags JXI devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K260245SILKBridgeKLISBio S.r.l.Apr 9, 2026Traditional
K253363NeuroSpan BridgeAuxilium Biotechnologies, Inc.Jan 17, 2026Traditional
K251505VersaCoat Nerve Protector (VTP-44G2); VersaCoat Nerve Protector (VTP-12G1)Alafair BiosciencesJul 22, 2025Traditional
K251175VersaWrap Nerve Protector (VTP-2201); VersaWrap Nerve Protector (VTP-1201)Alafair BiosciencesJul 17, 2025Traditional
K242113Nerve Wrap (07-DW-001-TAB)Biocircuit Technologies, Inc.Apr 2, 2025Traditional
K243889Remplir (ON-152, 15 x 20 mm); Remplir (ON-203, 20 x 30 mm); Remplir (ON-304, 30 x 40 mm); Remplir (ON-405, 40 x 50 mm)Orthocell, Ltd.Apr 2, 2025Traditional
K233322Mochida Nerve CuffMochida Pharmaceutical Co., Ltd.Jun 21, 2024Traditional
K233533NerveTapeBiocircuit Technologies, Inc.Feb 12, 2024Traditional
K230794Rebuilder Nerve Guidance ConduitCelestray Biotech Company, LLC.,Jan 29, 2024Traditional
K232029VersaWrap Nerve ProtectorAlafair Biosciences, Inc.Nov 2, 2023Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 40 with a free account)

Clearances by year

29 JXI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)291
2025499
20243266
20233122
20222525
2020190
20191114
2018189
2017390
20163117
20151338
20143309
20121500
2011173

Who submits

20 applicants cleared a JXI device since 2011. 62% of the clearances went to applicants in United States, then Australia (7%), Germany (7%) and Japan (7%). By type: Traditional 90% and Special 10%.

ApplicantClearances since 2011
Axogen Corporation3
Alafair Biosciences2
Alafair Biosciences, Inc.2
Biocircuit Technologies, Inc.2
Collagen Matrix, Inc.2
Cook Biotech Incorporated2
Integra LifeSciences Corporation2
Medovent GmbH2

How FDA classifies it

Class II (performance standards).

From 21 CFR 882.5275.

Standards

21 CFR 882.5275 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent JXI clearances declared.

Ask about JXI

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about JXI

What is FDA product code JXI?

Product code JXI, “Cuff, Nerve” in FDA's classification database, is a Class II device type under 21 CFR 882.5275 (nerve cuff), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 40 clearances under JXI, 29 of them since 2011.

How many 510(k) clearances are there under JXI?

FDA’s 510(k) database listed 40 clearances under JXI as of Oct 29, 2026, 29 of them decided since 2011; the most recent decision was Apr 9, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a JXI 510(k)?

For the 6 JXI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 99 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most JXI clearances?

Since 2011: Axogen Corporation (3), Alafair Biosciences (2), Alafair Biosciences, Inc. (2), Biocircuit Technologies, Inc. (2) and Collagen Matrix, Inc. (2). 20 applicants have cleared a JXI device in that time.

Sources

  1. FDA product classification: JXI · Product Classification database
  2. 21 CFR 882.5275: Nerve cuff · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for JXI · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow JXIGet an email when FDA clears, recalls or publishes guidance for JXI devices.

Know what FDA already cleared.